Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline
- PMID: 30563885
- DOI: 10.1136/bmj.k5130
Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline
Erratum in
-
Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.BMJ. 2019 Jan 10;364:l103. doi: 10.1136/bmj.l103. BMJ. 2019. PMID: 30630830 No abstract available.
Abstract
WHAT IS THE ROLE OF DUAL ANTIPLATELET THERAPY AFTER HIGH RISK TRANSIENT ISCHAEMIC ATTACK OR MINOR STROKE? SPECIFICALLY, DOES DUAL ANTIPLATELET THERAPY WITH A COMBINATION OF ASPIRIN AND CLOPIDOGREL LEAD TO A GREATER REDUCTION IN RECURRENT STROKE AND DEATH OVER THE USE OF ASPIRIN ALONE WHEN GIVEN IN THE FIRST 24 HOURS AFTER A HIGH RISK TRANSIENT ISCHAEMIC ATTACK OR MINOR ISCHAEMIC STROKE? AN EXPERT PANEL PRODUCED A STRONG RECOMMENDATION FOR INITIATING DUAL ANTIPLATELET THERAPY WITHIN 24 HOURS OF THE ONSET OF SYMPTOMS, AND FOR CONTINUING IT FOR 10-21 DAYS CURRENT PRACTICE IS TYPICALLY TO USE A SINGLE DRUG.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the BMJ Rapid Recommendations interests disclosure form, and a description of all disclosures is reported in appendix 1 on bmj.com. As with all BMJ Rapid Recommendations, the executive team and The BMJ judged that no panel member had any financial conflict of interest. Professional and academic interests are minimised as much as possible, while maintaining necessary expertise on the panel to make fully informed decisions.
Comment in
-
Guideline: Starting dual antiplatelet therapy ≤ 24 h after high-risk TIA or minor ischemic stroke is recommended.Ann Intern Med. 2019 Apr 16;170(8):JC38. doi: 10.7326/ACPJ201904160-038. Ann Intern Med. 2019. PMID: 30986828 No abstract available.
Similar articles
-
Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.BMJ. 2018 Dec 18;363:k5108. doi: 10.1136/bmj.k5108. BMJ. 2018. PMID: 30563866 Free PMC article.
-
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.Health Technol Assess. 2018 Aug;22(48):1-76. doi: 10.3310/hta22480. Health Technol Assess. 2018. PMID: 30179153 Free PMC article. Clinical Trial.
-
Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.J Thromb Thrombolysis. 2019 Feb;47(2):233-247. doi: 10.1007/s11239-018-1786-z. J Thromb Thrombolysis. 2019. PMID: 30511260
-
Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.BMJ Open. 2016 Mar 17;6(3):e009013. doi: 10.1136/bmjopen-2015-009013. BMJ Open. 2016. PMID: 26988347 Free PMC article. Review.
-
[Dual antiplatelet therapy for secondary stroke prevention in patients with acute ischemic stroke. CIERTO group recommendation].Medicina (B Aires). 2019;79(4):315-321. Medicina (B Aires). 2019. PMID: 31487255 Review. Spanish.
Cited by
-
Intravenous thrombolysis versus dual antiplatelet therapy in minor ischemic stroke within the thrombolytic window (TAMIS): a multicenter cohort study.J Thromb Thrombolysis. 2024 Oct;57(7):1172-1182. doi: 10.1007/s11239-024-03032-8. Epub 2024 Aug 23. J Thromb Thrombolysis. 2024. PMID: 39179951
-
Intravenous thrombolysis versus dual antiplatelet therapy for patients with acute minor ischaemic stroke: a systematic review and meta-analysis.Front Pharmacol. 2024 Jun 10;15:1377475. doi: 10.3389/fphar.2024.1377475. eCollection 2024. Front Pharmacol. 2024. PMID: 38915465 Free PMC article.
-
Effect of Clopidogrel combined with aspirin in the treatment of acute progressive cerebral infarction: A retrospective single-center analysis.Pak J Med Sci. 2024 May-Jun;40(5):891-895. doi: 10.12669/pjms.40.5.9206. Pak J Med Sci. 2024. PMID: 38827855 Free PMC article.
-
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.Lancet Neurol. 2024 Jan;23(1):46-59. doi: 10.1016/S1474-4422(23)00403-9. Lancet Neurol. 2024. PMID: 38101902 Clinical Trial.
-
Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom.Cardiol Ther. 2023 Dec;12(4):675-687. doi: 10.1007/s40119-023-00332-7. Epub 2023 Oct 4. Cardiol Ther. 2023. PMID: 37789237 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical